Other Hematology Learning Center CME/CE

• 10.75 90.75
  Peer-to-Peer Clinical Connections: Sequencing Radioligand Therapies in Metastatic Castration-Resistant Prostate Cancer
  Medscape Education Oncology March 14, 2023
  Did you know that radiopharmaceuticals for the treatment of metastatic castration-resistant prostate cancer (mCRPC) care have the potential to prolong survival and optimize the quality of life?
  
  0.75 CMEMIN 0.75 ABIM MOCMIN

  
  Save
• 10.25 90.25
  All for One in CKD Anemia Care
  Medscape Education Infectious Diseases March 09, 2023
  Which specialists should be on your team in order to effectively manage anemia in patients with chronic kidney disease (CKD)?
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 10.75 90.75
  Emerging Data From New Orleans on Classical Hematologic Disorders
  Medscape Education Oncology March 02, 2023
  Are you up to date on recent data for clinical trials studying new therapies for classical hematologic disorders?
  
  0.75 CMEMIN 0.75 ABIM MOCMIN

  
  Save
• 11.50 91.50 21.50 31.50
  Chronic Leukemias
  Medscape Education Oncology March 02, 2023
  Do you know the latest approaches to treating chronic leukemias?
  
  1.50 CME/CEMIN 1.50 ABIM MOCMIN 1.50 CEMIN 1.50 CEMIN

  
  Save
• 10.25 90.25
  Are Gaps in Anemia and CKD Equal Across the Board?
  Medscape Education Nephrology March 02, 2023
  Is there a discrepancy in treatment of anemia in racial/ethnic minority patient populations with chronic kidney disease (CKD)?
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 10.50 90.50
  Emerging Approaches to Myelofibrosis Management
  Medscape Education Oncology March 01, 2023
  What’s new in the treatment of myelofibrosis (MF)? Join to hear an overview of the latest data on new and emerging agents.
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 12.50 92.50 22.50 32.50
  Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Neoplasms
  Medscape Education Oncology February 22, 2023
  Expand your knowledge and skills by exploring the latest data on leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.
  
  2.50 CME/CEMIN 2.50 ABIM MOCMIN 2.50 CEMIN 2.50 CEMIN

  
  Save
• 10.50 90.50 20.50 30.50
  Higher-Risk Myelodysplastic Syndrome: A Team Approach to Optimizing Outcomes
  Medscape Education Oncology February 24, 2023
  Did you know there is a new way to categorize patients with myelodysplastic syndrome (MDS) that includes molecular information?
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN 0.50 CEMIN

  
  Save
• 11.00 91.00 21.00 31.00
  Managing Treatment-Naive Chronic Lymphocytic Leukemia With BTK Inhibitors: Test Your Skills
  Medscape Education Oncology February 24, 2023
  How would you treat these patients with chronic lymphocytic leukemia (CLL)?
  
  1.00 CME/CEMIN 1.00 ABIM MOCMIN 1.00 CEMIN 1.00 CEMIN

  
  Save
• 10.25 90.25
  Anemia of CKD: Consequences of Missing the Boat
  Medscape Education Nephrology February 23, 2023
  How does anemia in patients with chronic kidney disease (CKD) affect their health, quality of life, and economic situation?
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 12.00 92.00 22.00 32.00
  Myeloma, Lymphoma, and Benign Hematology
  Medscape Education Oncology February 22, 2023
  Expand your knowledge and skills by exploring the latest data in myeloma, lymphoma, and benign hematology.
  
  2.00 CME/CEMIN 2.00 ABIM MOCMIN 2.00 CEMIN 2.00 CEMIN

  
  Save
• 10.50 90.50
  What’s New in Cholangiocarcinoma: Updates From the Annual American Gastrointestinal Cancer Symposium
  Medscape Education Oncology February 22, 2023
  Are you up to date on the latest data on the management of cholangiocarcinoma and how it applies to clinical practice?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 14.25 94.25 24.25 34.25
  CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
  Morbidity & Mortality Weekly Report February 21, 2023
  What are the new updates to the guidelines for prescribing opioids for pain in adults?
  
  4.25 CME/CEMIN 4.25 ABIM MOCMIN 4.25 CEMIN 4.25 CEMIN

  
  Save
• 11.00 91.00
  Associations of Clonal Hematopoiesis With Recurrent Vascular Events and Death in Patients With Incident Ischemic Stroke
  Blood February 16, 2023
  Identifying genetic/other CH risk factors may improve personalized risk stratification and secondary prevention in ischemic stroke.
  
  1.00 CMEMIN 1.00 ABIM MOCMIN

  
  Save
• 10.25 90.25
  Anemia of CKD… Are We Missing the Boat?
  Medscape Education Nephrology February 16, 2023
  Do you know which patients with chronic kidney disease (CKD) should be screened for anemia and how to effectively manage anemia in patients with CKD?
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 10.50 90.50 20.50
  An Interprofessional Approach to Anemia of Chronic Kidney Disease: Complete the Team for Improved Patient Care 
  Medscape Education Nephrology February 14, 2023
  Are you up to date on team-based approaches to address the burdens of anemia of chronic kidney disease (CKD)?
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN

  
  Save
• 10.25 90.25
  Anemia of CKD… The Science Behind the Disease
  Medscape Education Nephrology February 09, 2023
  Learn about the pathophysiology of anemia in patients with chronic kidney disease (CKD) to better understand emerging treatment strategies.
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 11.25 91.25
  Harnessing the Power of Emerging Therapies in the Management of Patients With Pancreatic Cancer
  Medscape Education Oncology February 08, 2023
  Did you know that pancreatic cancer remains a deadly condition that is often not discovered until the metastatic stage?
  
  1.25 CMEMIN 1.25 ABIM MOCMIN

  
  Save
• 10.75 90.75 20.75 30.75
  Acute Myeloid Leukemia and the Role of FLT3 Inhibitors: Best Practices for the Interprofessional Care Team
  Medscape Education Oncology January 30, 2023
  What’s new in FLT3 acute myeloid leukemia (AML)? Join to hear a panel of experts discuss how they use FLT3 inhibitors in patients with AML.
  
  0.75 CME/CEMIN 0.75 ABIM MOCMIN 0.75 CEMIN 0.75 CEMIN

  
  Save
• 10.50 90.50 20.50 30.50
  Risk-Adapted Management of Multiple Myeloma in the Era of Modern Therapy
  Medscape Education Oncology January 27, 2023
  Are you prepared to bring novel therapies to the clinic? Myeloma experts break down the practical considerations.
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN 0.50 CEMIN

  
  Save